Evotec (EVO) vs Glass House Brands Subordinate Voting Shares (GLAS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Glass House Brands Subordinate Voting Shares (GLAS) has outperformed Evotec (EVO) over the past year, losing 36.7% versus a loss of 58.9%. Over five years, GLAS leads with a +2.7% price change compared with -92.9% for EVO. Evotec is the larger company by market cap ($550.9 million vs $416.6 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EVO | GLAS |
|---|---|---|
| Share price | $1.55 | $4.42 |
| Market cap | $550.85M | $416.55M |
| 1-day change | -3.73% | -13.84% |
| YTD return | -47.73% | -42.03% |
| 1-year return | -58.93% | -36.67% |
| 5-year return | -92.87% | +2.70% |
| Forward P/E | — | 19.64 |
| EPS (TTM) | $-0.64 | $-0.74 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.27 | $13.93 |
| 52-week low | $1.50 | $4.36 |
| Distance from 52-week high | -63.70% | -68.27% |
| Analyst consensus | none | none |
| Avg. price target upside | +168.39% | +261.99% |
| Average volume | 103.98K | 736.52K |
| Shares outstanding | 355.39M | 88.00M |
| Employees | 4,461 | 357 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GLAS has outperformed EVO by 22.3 percentage points over the past year.
About Evotec
EVO stock →Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just Evotec Biologics.
Health Care · Biotechnology: Pharmaceutical Preparations · 4,461 employees
About Glass House Brands Subordinate Voting Shares
GLAS stock →Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. It operates through three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods.
Health Care · Medicinal Chemicals and Botanical Products · 357 employees
EVO vs GLAS FAQ
Which is bigger, Evotec or Glass House Brands Subordinate Voting Shares?
Evotec (EVO) is larger, with a market capitalization of $550.85M compared with $416.55M for Glass House Brands Subordinate Voting Shares (GLAS).
Which stock has performed better over the past year, EVO or GLAS?
GLAS returned -36.67% over the past 12 months, compared with -58.93% for EVO (price return, excluding dividends). Past performance does not predict future results.
Are Evotec and Glass House Brands Subordinate Voting Shares in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for Evotec and Medicinal Chemicals and Botanical Products for Glass House Brands Subordinate Voting Shares.